Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

​ Conditions: Non-Small Cell Lung Cancer (NSCLC)

Interventions: Drug: EGFR-TKI; Drug: PD-1/PD-L1 inhibitor; Drug: EGFR-TKI combined with PD-1/PD-L1

Sponsors: Wuhan Union Hospital, China

Completed Conditions: Non-Small Cell Lung Cancer (NSCLC)
Interventions: Drug: EGFR-TKI; Drug: PD-1/PD-L1 inhibitor; Drug: EGFR-TKI combined with PD-1/PD-L1
Sponsors: Wuhan Union Hospital, China
Completed